No Data
No Data
Evaluating BioNTech: Insights From 12 Financial Analysts
In the preceding three months, 12 analysts have released ratings for BioNTech (NASDAQ:BNTX), presenting a wide array of perspectives from bullish to bearish.The table below summarizes their recent rat
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $113 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.
BioNTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 34.05% HC Wainwright & Co. $113 → $113 Reiterates Buy → Buy 06/10/2024 34.05% HC Wainwright & C
H.C. Wainwright Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $113
H.C. Wainwright analyst Robert Burns maintains $BioNTech(BNTX.US)$ with a buy rating, and maintains the target price at $113.According to TipRanks data, the analyst has a success rate of 24.0% and a t
Unusual Options Activity: PPL, JD and Others Attract Market Bets, PPL V/OI Ratio Reaches 89.4
EST Jun 24th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan